Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-03-13

Clinical Trial Update: Boceprevir-based Therapy to Rescue HCV Genotype 1/HBV Infected Patients Refractory to Combination Therapy [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating boceprevir-based therapy to rescue patients with chronic hepatitis C genotype 1 coinfected with hepatitis B who are refractory to pri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Boceprevir (boceprevir)

Snippet

Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital | Conditions: Hepatitis C, Chronic | Phase 3 | Status: COMPLETED | Results posted: 2018-03-13